last published
Personalised medicine is increasingly moving from a specialist scientific discussion to a central question for health policy: how can health systems use genomic, molecular, clinical and digital information to deliver more targeted, effective and equitable care? A recent policy brief from the European Observatory on Health Systems and Policies, Personalized
NEWS
Be informed and stay informed on all
news, events and publication updated.
EVENTS
Be informed and stay informed on all
news, events and publication updated.
Dublin, 2 October 2026 — The European Alliance for Personalised Medicine will convene a high-level conference in Dublin on 2 October 2026, bringing together policymakers,
The European Alliance for Personalised Medicine will convene a dedicated ESMO session on “Personalised Oncology Across Health Systems: From Molecular Insight to Measurable Access” on
The European Alliance for Personalised Medicine (EAPM) participated in the Kick-Off Meeting of the Joint Action on Personalised Cancer Medicine (JA PCM) in Brussels, as
On 17–18 October 2025 in Berlin, the European Alliance for Personalised Medicine (EAPM) convened two key events aimed at accelerating the practical implementation of precision
The European Alliance for Personalised Medicine (EAPM) was pleased to participate and present at the official kick-off meeting of the ON-COME project, held on 6–7
The European Alliance for Personalised Medicine (EAPM) convened a high-level multi-stakeholder side event during the European Society of Pathology (ESP) Congress in Vienna, bringing together
2–3 September 2025, Club University Foundation in Brussels, visioneurope2030.com The European Alliance for Personalised Medicine (EAPM) is proud to host the upcoming VISION Europe 2030
July 15, 2025 | 12:00–14:00 CET | European Parliament, Brussels Hosted by MEP Seán Kelly Cancer is on track to become the leading cause of
